FDA
-
-
-
-
-
-
-
Silo Pharma (SILO) Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD
-
-
-
-
-
-
-
Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia
-
-
-
-
-
-
-
Silo Pharma (SILO) Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD
-
-
-
-
-
-
-
Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia
-
-
-
-
-
-
-
Silo Pharma, Inc. (SILO) Achieves New Milestone for SP-26 Therapeutic
-
-
-
-
-
-
-
Silo Pharma Initiates Toxicity Study of its Proprietary Ketamine Formulation for Treatment of Fibromyalgia
-
-
-
-
-
-
251,413 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All